Back to: products

Plasma Fractionation Market by Product, Application (Hematology, Immunology, Neurology, Critical care, Pulmonology, Hemato-oncology, Rheumatology, and Other Applications), End-User

PrintEmail
Mar 2021 - 114 Pages - From $4,000 (15% discount available)
Description

The report cover may be different from the image shown.

The product will be delivered by email. If you have any question, want to preview some sample pages, or ask for custom research, please contact us. You can also check with us for possible discount. It is possible now to buy a part of the report in terms of chapter, section, data table or figure.

Product and Price

By clicking the Add to Shopping Cart button, you certify to agree with our Terms of Service.

"The Plasma Fractionation Market is anticipated to grow at the rate of 6.8% CAGR by 2026. In the plasma fractionation process, protein products are fractionated from human plasma to prevent and treat life-threatening conditions like immunologic disorders, congenital deficiencies, etc. Fractionation is a process supported to separate a certain quantity of a mixture. Additionally, plasma is the fluid component of blood that is fractionated to find different plasma derivatives such as albumin and immunoglobulins. These derived plasma products have therapeutic effects and are employed to treat several disorders related to blood plasma. Also, immunoglobulins are active in the treatment of primary and secondary immune deficiencies. Flow in the geriatric population across the world, which is disposed to many rare diseases that require plasma derivatives, is the main factor that increases the plasma fractionation market development.
The rise in immunoglobulins and alpha-1-antitrypsin in medicine areas also fuels the plasma fractionation market's development. Additionally, the surge in plasma collection centers worldwide is another main factor contributing to this market's growth. Also, favorable government support to feast awareness related to the use of plasma resulting products propels the plasma fractionation market's development.
Plasma Fractionation Market by Product
• Immunoglobulins
• Intravenous Immunoglobulins
• Subcutaneous Immunoglobulins
• Other Immunoglobulins
• Coagulation Factor Concentrates
• Factor VIII
• Factor IX
• Von Willebrand Factor
• Prothrombin Complex Concentrate
• Fibrinogen Concentrates
• Factor XIII
• Albumin
• Protease Inhibitors
• Other Products
Plasma Fractionation Market by Application
• Hematology
• Immunology
• Neurology
• Critical care
• Pulmonology
• Hemato-oncology
• Rheumatology
• Other Applications
Plasma Fractionation Market by End User
• Hospitals & Clinics
• Clinical Research Laboratories
• Academic Institutes
Plasma Fractionation Market by Geography
• North America
• Europe
• Asia Pacific
• Rest of the World
Based on the product, the immunoglobulins segment is happening to hold a significant share in the plasma fractionation market. This segment growth is ascribed to immunoglobulins' different uses in several disorders, including primary and secondary immune deficiencies and inflammatory diseases. Globally, an increase in the R&D associated with immunology is another factor boosting the demand for immunoglobulins.
In terms of application, the plasma fractionation applications consist of hematology, immunology, neurology, critical care, pulmonology, hemato-oncology, rheumatology, and other applications. The neurology segment is registered the maximum share in the market due to intravenous immunoglobulin in less time than steroids and its efficacy on several peripheral and central nervous system disorders.
The plasma fractionation market's end-users are hospitals and clinics, clinical research laboratories, and academic institutes. The significant end-users of plasma fractionation are hospitals and clinics. Hospitals require plasma products to treat acute diseases, and the increasing number of patients in hospitals is the reason for fueling the demand for plasma fractionation.
The North America region is leading the plasma fractionation market share during the forecast period. This is due to well-developed healthcare facilities, beneficial government regulations, and rising research and development in plasma fractionation are the factors responsible for the enormous expansion of the market in this region.
Immunoglobulins are employed as the primary remedy for several neurologic, immunologic and hematologic conditions. The most usual immunoglobulin therapy usage is to treat primary immune deficiencies and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). The diagnosis percentage of several immunological diseases has increased over the past few years due to technological advancements. Besides, globally increasing genetic research for identifying and diagnosing immunodeficiency will surge in the clinical requirement for immunoglobulins, increasing the global plasma fractionation market growth.
The profiles of companies leading the plasma fractionation market include Bharat Serums and Vaccines Limited, Shanghai RAAS Blood Products, Japan Blood Products Organization, Green Cross Corporation, Grifols, Shire, Octapharma, LFB, Biotest, CSL, Sanquin, China Biologic Products, Bio Products Laboratory, Kedrion, Emergent BioSolutions and Intas Biopharmaceuticals.
As a result, plasma fractionation is a vital class of remedies often utilized as the only choice available to prevent, manage, and treat fatal health conditions such as trauma, hereditary deficiencies, immunologic disorders, or infections.
• This report delivers a comprehensive analysis of the plasma fractionation market growth drivers, restraints, opportunities, and other related challenges.
• This report depicts the market developments such as new product launches, mergers and acquisitions, diversification, and joint ventures of the market players.
• This report also describes all potential segments and sub-segments present in the market to help the companies in strategic business planning.
• This report also gives the regional analysis of the plasma fractionation market in terms of market penetration across the world." "Table of Contents
1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. PEST Analysis
3.2.2. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Evolution
4.2. Market Trends and Impact
4.3. Advantages/Disadvantages of Market
4.4. Regulatory Impact
4.5. Market Offerings
4.6. Market Segmentation
4.7. Market Dynamics
4.7.1. Drivers
4.7.2. Restraints
4.7.3. Opportunities
4.8. DRO - Impact Analysis
5. Product: Market Size & Analysis
5.1. Overview
5.2. Immunoglobulins
5.3. Intravenous Immunoglobulins
5.4. Subcutaneous Immunoglobulins
5.5. Other Immunoglobulins
5.6. Coagulation Factor Concentrates
5.7. Factor VIII
5.8. Factor IX
5.9. Von Willebrand Factor
5.10. Prothrombin Complex Concentrate
5.11. Fibrinogen Concentrates
5.12. Factor XIII
5.13. Albumin
5.14. Protease Inhibitors
5.15. Other Products
6. Application: Market Size & Analysis
6.1. Overview
6.2. Hematology
6.3. Immunology
6.4. Neurology
6.5. Critical care
6.6. Pulmonology
6.7. Hemato-oncology
6.8. Rheumatology
6.9. Other Applications
7. End-User: Market Size & Analysis
7.1. Overview
7.2. Hospitals & Clinics
7.3. Clinical Research Laboratories
7.4. Academic Institutes
8. Geography: Market Size & Analysis
8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World
9. Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. Vendor Profiles
10.1. Bharat Serums and Vaccines Limited
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. Shanghai RAAS Blood Products
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. Japan Blood Products Organization
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. Green Cross Corporation
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. Grifols
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. Shire
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. Octapharma
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. LFB
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. Biotest
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. CSL
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. Companies to Watch
11.1. Sanquin
11.1.1. Overview
11.1.2. Market
11.1.3. Business Strategy
11.2. China Biologic Products
11.2.1. Overview
11.2.2. Market
11.2.3. Business Strategy
11.3. Bio Products Laboratory
11.3.1. Overview
11.3.2. Market
11.3.3. Business Strategy
11.4. Kedrion
11.4.1. Overview
11.4.2. Market
11.4.3. Business Strategy
11.5. Emergent BioSolutions
11.5.1. Overview
11.5.2. Market
11.5.3. Business Strategy
11.6. Intas Biopharmaceuticals
11.6.1. Overview
11.6.2. Market
11.6.3. Business Strategy
12. Analyst Opinion
13. Annexure
13.1. Report Scope
13.2. Market Definitions
13.3. Research Methodology
13.3.1. Data Collation and In-house Estimation
13.3.2. Market Triangulation
13.3.3. Forecasting
13.4. Report Assumptions
13.5. Declarations
13.6. Stakeholders
13.7. Abbreviations" "Tables
TABLE 1. GLOBAL PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
TABLE 2. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR IMMUNOGLOBULINS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 3. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR INTRAVENOUS IMMUNOGLOBULINS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 4. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR SUBCUTANEOUS IMMUNOGLOBULINS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 5. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR OTHER IMMUNOGLOBULINS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 6. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR COAGULATION FACTOR CONCENTRATES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 7. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR FACTOR VIII, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 8. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR FACTOR IX, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 9. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR VON WILLEBRAND FACTOR, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 10. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR PROTHROMBIN COMPLEX CONCENTRATE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 11. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR FIBRINOGEN CONCENTRATES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 12. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR FACTOR XIII, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 13. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR ALBUMIN, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 14. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR PROTEASE INHIBITORS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 15. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR OTHER PRODUCTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 16. GLOBAL PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 17. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR HEMATOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 18. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR IMMUNOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 19. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR NEUROLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 20. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR CRITICAL CARE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 21. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR PULMONOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 22. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR HEMATO-ONCOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 23. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR RHEUMATOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 24. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR OTHER APPLICATIONS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 25. GLOBAL PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
TABLE 26. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR HOSPITALS & CLINICS, 2020-2026 (USD BILLION)
TABLE 27. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR CLINICAL RESEARCH LABORATORIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 28. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR ACADEMIC INSTITUTES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
TABLE 29. NORTH AMERICA PLASMA FRACTIONATION MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 30. NORTH AMERICA PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
TABLE 31. NORTH AMERICA PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 32. NORTH AMERICA PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
TABLE 33. U.S PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
TABLE 34. U.S PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 35. U.S PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
TABLE 36. CANADA PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
TABLE 37. CANADA PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 38. CANADA PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
TABLE 39. EUROPE PLASMA FRACTIONATION MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 40. EUROPE PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
TABLE 41. EUROPE PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 42. EUROPE PLASMA FRACTIONATION MARKET VALUE, END-USER, 2020-2026 (USD BILLION)
TABLE 43. GERMANY PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
TABLE 44. GERMANY PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 45. GERMANY PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
TABLE 46. U.K PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
TABLE 47. U.K PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 48. U.K PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
TABLE 49. FRANCE PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
TABLE 50. FRANCE PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 51. FRANCE PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
TABLE 52. ITALY PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
TABLE 53. ITALY PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 54. ITALY PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
TABLE 55. SPAIN PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
TABLE 56. SPAIN PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 57. SPAIN PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
TABLE 58. ROE PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
TABLE 59. ROE PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 60. ROE PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
TABLE 61. ASIA PACIFIC PLASMA FRACTIONATION MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
TABLE 62. ASIA PACIFIC PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
TABLE 63. ASIA PACIFIC PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 64. ASIA PACIFIC PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
TABLE 65. CHINA PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
TABLE 66. CHINA PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 67. CHINA PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
TABLE 68. INDIA PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
TABLE 69. INDIA PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 70. INDIA PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
TABLE 71. JAPAN PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
TABLE 72. JAPAN PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 73. JAPAN PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
TABLE 74. REST OF APAC PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
TABLE 75. REST OF APAC PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 76. REST OF APAC PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
TABLE 77. REST OF WORLD PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
TABLE 78. REST OF WORLD PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
TABLE 79. REST OF WORLD PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
TABLE 80. BHARAT SERUMS AND VACCINES LIMITED: FINANCIALS
TABLE 81. BHARAT SERUMS AND VACCINES LIMITED: PRODUCTS & SERVICES
TABLE 82. BHARAT SERUMS AND VACCINES LIMITED: RECENT DEVELOPMENTS
TABLE 83. SHANGHAI RAAS BLOOD PRODUCTS: FINANCIALS
TABLE 84. SHANGHAI RAAS BLOOD PRODUCTS: PRODUCTS & SERVICES
TABLE 85. SHANGHAI RAAS BLOOD PRODUCTS: RECENT DEVELOPMENTS
TABLE 86. JAPAN BLOOD PRODUCTS ORGANIZATION: FINANCIALS
TABLE 87. JAPAN BLOOD PRODUCTS ORGANIZATION: PRODUCTS & SERVICES
TABLE 88. JAPAN BLOOD PRODUCTS ORGANIZATION: RECENT DEVELOPMENTS
TABLE 89. GREEN CROSS CORPORATION: FINANCIALS
TABLE 90. GREEN CROSS CORPORATION: PRODUCTS & SERVICES
TABLE 91. GREEN CROSS CORPORATION: RECENT DEVELOPMENTS
TABLE 92. GRIFOLS: FINANCIALS
TABLE 93. GRIFOLS: PRODUCTS & SERVICES
TABLE 94. GRIFOLS: RECENT DEVELOPMENTS
TABLE 95. SHIRE: FINANCIALS
TABLE 96. SHIRE: PRODUCTS & SERVICES
TABLE 97. SHIRE: RECENT DEVELOPMENTS
TABLE 98. OCTAPHARMA: FINANCIALS
TABLE 99. OCTAPHARMA: PRODUCTS & SERVICES
TABLE 100. OCTAPHARMA: RECENT DEVELOPMENTS
TABLE 101. LFB: FINANCIALS
TABLE 102. LFB: PRODUCTS & SERVICES
TABLE 103. LFB: RECENT DEVELOPMENTS
TABLE 104. BIOTEST: FINANCIALS
TABLE 105. BIOTEST: PRODUCTS & SERVICES
TABLE 106. BIOTEST: RECENT DEVELOPMENTS
TABLE 107. CSL: FINANCIALS
TABLE 108. CSL: PRODUCTS & SERVICES
TABLE 109. CSL: RECENT DEVELOPMENTS
TABLE 110. SANQUIN: PRODUCTS & SERVICES
TABLE 111. CHINA BIOLOGIC PRODUCTS: PRODUCTS & SERVICES
TABLE 112. BIO PRODUCTS LABORATORY: PRODUCTS & SERVICES
TABLE 113. KEDRION: PRODUCTS & SERVICES
TABLE 114. EMERGENT BIOSOLUTIONS: PRODUCTS & SERVICES
TABLE 115. INTAS BIOPHARMACEUTICALS: PRODUCTS & SERVICES " "Charts
CHART. 1. GLOBAL PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
CHART. 2. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR IMMUNOGLOBULINS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 3. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR INTRAVENOUS IMMUNOGLOBULINS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 4. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR SUBCUTANEOUS IMMUNOGLOBULINS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 5. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR OTHER IMMUNOGLOBULINS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 6. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR COAGULATION FACTOR CONCENTRATES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 7. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR FACTOR VIII, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 8. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR FACTOR IX, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 9. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR VON WILLEBRAND FACTOR, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 10. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR PROTHROMBIN COMPLEX CONCENTRATE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 11. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR FIBRINOGEN CONCENTRATES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 12. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR FACTOR XIII, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 13. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR ALBUMIN, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 14. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR PROTEASE INHIBITORS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 15. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR OTHER PRODUCTS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 16. GLOBAL PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 17. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR HEMATOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 18. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR IMMUNOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 19. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR NEUROLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 20. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR CRITICAL CARE, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 21. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR PULMONOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 22. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR HEMATO-ONCOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 23. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR RHEUMATOLOGY, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 24. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR OTHER APPLICATIONS, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 25. GLOBAL PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
CHART. 26. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR HOSPITALS & CLINICS, 2020-2026 (USD BILLION)
CHART. 27. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR CLINICAL RESEARCH LABORATORIES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 28. GLOBAL PLASMA FRACTIONATION MARKET VALUE FOR ACADEMIC INSTITUTES, BY GEOGRAPHY, 2020-2026 (USD BILLION)
CHART. 29. NORTH AMERICA PLASMA FRACTIONATION MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 30. NORTH AMERICA PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
CHART. 31. NORTH AMERICA PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 32. NORTH AMERICA PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
CHART. 33. U.S PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
CHART. 34. U.S PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 35. U.S PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
CHART. 36. CANADA PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
CHART. 37. CANADA PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 38. CANADA PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
CHART. 39. EUROPE PLASMA FRACTIONATION MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 40. EUROPE PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
CHART. 41. EUROPE PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 42. EUROPE PLASMA FRACTIONATION MARKET VALUE, END-USER, 2020-2026 (USD BILLION)
CHART. 43. GERMANY PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
CHART. 44. GERMANY PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 45. GERMANY PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
CHART. 46. U.K PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
CHART. 47. U.K PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 48. U.K PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
CHART. 49. FRANCE PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
CHART. 50. FRANCE PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 51. FRANCE PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
CHART. 52. ITALY PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
CHART. 53. ITALY PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 54. ITALY PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
CHART. 55. SPAIN PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
CHART. 56. SPAIN PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 57. SPAIN PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
CHART. 58. ROE PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
CHART. 59. ROE PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 60. ROE PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
CHART. 61. ASIA PACIFIC PLASMA FRACTIONATION MARKET VALUE, BY COUNTRY, 2020-2026 (USD BILLION)
CHART. 62. ASIA PACIFIC PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
CHART. 63. ASIA PACIFIC PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 64. ASIA PACIFIC PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
CHART. 65. CHINA PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
CHART. 66. CHINA PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 67. CHINA PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
CHART. 68. INDIA PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
CHART. 69. INDIA PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 70. INDIA PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
CHART. 71. JAPAN PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
CHART. 72. JAPAN PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 73. JAPAN PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
CHART. 74. REST OF APAC PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
CHART. 75. REST OF APAC PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 76. REST OF APAC PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)
CHART. 77. REST OF WORLD PLASMA FRACTIONATION MARKET VALUE, BY PRODUCT, 2020-2026 (USD BILLION)
CHART. 78. REST OF WORLD PLASMA FRACTIONATION MARKET VALUE, BY APPLICATION, 2020-2026 (USD BILLION)
CHART. 79. REST OF WORLD PLASMA FRACTIONATION MARKET VALUE, BY END-USER, 2020-2026 (USD BILLION)"

Reviews

There are yet no reviews for this product.